Benefits of participating in the clinical study
Find out if you are eligible to try AlloNK®, an investigative treatment in a clinical study
This study will see how well AlloNK® treats systemic lupus erythematosus (SLE) and/or lupus nephritis. Participation includes 26 office visits over 2 years.
Access to an investigative treatment that may work for you
Compensation and incentives
Extra tests and monitoring from study doctors
A clinical trial or clinical study looks at better ways to prevent, diagnose, and treat disease. This clinical study will see how well AlloNK® treats systemic lupus erythematosus and/or lupus nephritis in combination with rituximab or obinutuzumab.
AlloNK® is a treatment made from natural sources taken from cord blood. It is designed to boost the immune system by using cells from a donor. It’s meant to work with other treatments and can be given outside the hospital, in places like clinics or doctor’s offices.
The study will take around 24 months. You will have 26 office visits over the 2 years.
Your participation in this clinical study helps us learn more about systemic lupus erythematosus (SLE) and/or lupus nephritis and, hopefully, find a new and accessible treatment.
If you participate in this clinical study, you will get:
-
Access to trying an investigative treatment that may work for you
-
Compensation and incentives
-
Extra tests and monitoring from study doctors
-
While we try to lower risks as much as possible, some side effects may occur. But the clinical study team will watch you closely, adding another layer of care.
If you are an adult with systemic lupus erythematosus (SLE) and/or lupus nephritis and other treatments have not worked well, this could be the right study for you. Talk with the clinical study coordinator and your doctor to help make your decision.
AlloNK® for Lupus Nephritis - FAQ
Common Questions
Please complete the form and we will contact you with more information.
I am Interested in the clinical study!
